Subchronic toxicity studies with rodents can help predict appropriate doses of your compound for future chronic toxicity studies and allow future long-term toxicity or efficacy studies to be designed with special emphasis on identified target organs.
vivoPharm's subchronic studies can include:
Repeat dose toxicity (all routes of administration)
Intramuscular and subcutaneous toxicity
Subchronic toxicity (all routes of administration)
Chronic toxicity test (6-24 months)
Combined chronic toxicity / carcinogenicity studies